Atlas Trials

Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer

Clinical trial NCT05129046 · UNKNOWN

Trial details

NCT number
NCT05129046
Sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Status
UNKNOWN
Study type
OBSERVATIONAL
Colorectal Cancer
Start date
2021-12-15
Primary completion
2024-04-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.